BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation Journal Article


Authors: Li, B.; An, W.; Wang, H.; Baslan, T.; Mowla, S.; Krishnan, A.; Xiao, W.; Koche, R. P.; Liu, Y.; Cai, S. F.; Xiao, Z.; Derkach, A.; Iacobucci, I.; Mullighan, C. G.; Helin, K.; Lowe, S. W.; Levine, R. L.; Rampal, R. K.
Article Title: BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation
Abstract: Leukemic transformation (LT) of myeloproliferative neoplasm (MPN) has a dismal prognosis and is largely fatal. Mutational inactivation of TP53 is the most common somatic event in LT; however, the mechanisms by which TP53 mutations promote LT remain unresolved. Using an allelic series of mouse models of Jak2/Trp53 mutant MPN, we identify that only biallelic inactivation of Trp53 results in LT (to a pure erythroleukemia [PEL]). This PEL arises from the megakaryocyte-erythroid progenitor population. Importantly, the bone morphogenetic protein 2/SMAD pathway is aberrantly activated during LT and results in abnormal self-renewal of megakaryocyte-erythroid progenitors. Finally, we identify that Jak2/Trp53 mutant PEL is characterized by recurrent copy number alterations and DNA damage. Using a synthetic lethality strategy, by targeting active DNA repair pathways, we show that this PEL is highly sensitive to combination WEE1 and poly(ADP-ribose) polymerase inhibition. These observations yield new mechanistic insights into the process of p53 mutant LT and offer new, clinically translatable therapeutic approaches. © 2022 American Society of Hematology
Keywords: myeloproliferative disorders; genetics; mutation; myeloproliferative disorder; janus kinase 2; mouse; animal; metabolism; animals; mice; protein p53; tumor suppressor protein p53; bone morphogenetic protein 2; megakaryocyte; megakaryocytes; megakaryocyte erythroid progenitor; bmp2 protein, mouse; megakaryocyte-erythroid progenitor cells
Journal Title: Blood
Volume: 139
Issue: 25
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-06-23
Start Page: 3630
End Page: 3646
Language: English
DOI: 10.1182/blood.2021014465
PUBMED: 35421216
PROVIDER: scopus
PMCID: PMC9728578
DOI/URL:
Notes: Article -- Export Date: 1 August 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Raajit Kumar Rampal
    338 Rampal
  2. Ross Levine
    775 Levine
  3. Sheng Feng Cai
    44 Cai
  4. Wenbin Xiao
    108 Xiao
  5. Bing Li
    8 Li
  6. Ying Liu
    33 Liu
  7. Andriy Derkach
    148 Derkach
  8. Shoron Mowla
    10 Mowla
  9. Wenbin An
    4 An